Search results
Results from the WOW.Com Content Network
Dana–Farber Cancer Institute (DFCI) is a comprehensive cancer treatment and research center in Boston, Massachusetts.Dana-Farber is the founding member of the Dana-Farber/Harvard Cancer Center, Harvard's Comprehensive Cancer Center designated by the National Cancer Institute, and one of the 15 clinical affiliates and research institutes of Harvard Medical School.
That study found that the two ratings systems frequently made different recommendations for the best hospitals. [ 3 ] A 2009 study concluded that when a hospital's place in U.S. News rankings changed, then consequently there could be as much as a 5% change in certain kinds of patient admissions to that hospital which might be attributed to that ...
Subsequently she trained at the University of California, San Francisco and Dana–Farber Cancer Institute. In 2007, she received a masters in public health from Harvard University . [ 1 ] [ 2 ] As of 2021, Ng is a physician at the Dana–Farber Cancer Institute and a professor at Harvard Medical School . [ 3 ]
Loren David Walensky is an American physician-scientist and pediatric oncologist at the Dana–Farber Cancer Institute since 2003 and a professor of pediatrics at the Dana–Farber/Harvard Cancer Center. He researches peptides and oncogenic pathways. In 2013, Walensky became director of the joint MD/PhD program at Harvard Medical School. [1]
In July 2015, Haas-Kogan succeeded Jay Harris as Chair of the Department of Radiation Oncology at the Dana–Farber Cancer Institute, Brigham and Women’s Hospital (BWHC), and Boston Children’s Hospital. She was also appointed professor at Harvard Medical School and become an endowed professor of Radiation Oncology at BWHC. [3]
The lead singer of the Four Tops said a Detroit-area hospital restrained him and ordered a psychological exam after refusing to believe that he was part of the Motown music group. Alexander Morris ...
Edward J. Benz Jr. is the former president of Dana–Farber Cancer Institute in Boston, Massachusetts., [1] and the Richard and Susan Smith Professor of Medicine [2] as well as a professor of genetics at Harvard Medical School. [3] He was named to the presidency of Dana-Farber in 2000, succeeding David G. Nathan. [4]
David M. Livingston (29 March 1941 – 17 October 2021) [1] was the Deputy Director of the Dana-Farber/Harvard Cancer Center, Emil Frei Professor of Genetics and Medicine at Harvard Medical School, Chairman of the Executive Committee for Research at Dana–Farber Cancer Institute. [2] Dr. Livingston joined the Harvard faculty in 1973. [3]